June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Reduced Energy Macular Laser Phototherapy for the Treatment of Diabetic Macular Edema
Author Affiliations & Notes
  • Alessandro Dare
    Ophthalmology, CBEO, Ribeirao Preto, Brazil
    Retina, Consultores de Retina e Vítreo, Ribeirão Preto, Brazil
  • Jose Cardillo
    Ophthalmology, Federal University of São Paulo, São Paulo, Brazil
    Ophthalmology, University of São Paulo - USP, Ribeirão Preto, Brazil
  • Rodrigo Jorge
    Ophthalmology, University of São Paulo - USP, Ribeirão Preto, Brazil
  • Rubens Belfort
    Ophthalmology, Federal University of São Paulo, São Paulo, Brazil
  • Michel Farah
    Ophthalmology, Federal University of São Paulo, São Paulo, Brazil
  • Footnotes
    Commercial Relationships Alessandro Dare, None; Jose Cardillo, None; Rodrigo Jorge, None; Rubens Belfort, CNPQ (F), FAPESP (F), ALCON (C), ALLERGAN (R), BAYER (R), NOVABAY (R), ALCON (R); Michel Farah, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2375. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Alessandro Dare, Jose Cardillo, Rodrigo Jorge, Rubens Belfort, Michel Farah, Pan-American Collaborative Retina Study (PACORES); Reduced Energy Macular Laser Phototherapy for the Treatment of Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2375.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Exploiting optimized parameters and treatment guidelines will be the key to progress macular photocoagulation for an ultimate tissue injury minimization and vision restoration. The purpose of this investigation is to determine the anatomical and functional outcome of this suggested optimized treatment technique consisting of confluent (high density) and barely visible photocoagulation lesions in patients with diabetic macular edema (DME).

Methods: Twenty-eight eyes of 21 patients with DME were treated using a yellow diode laser (577 nm) clinically adjusted to show barely visible photocoagulation lesions at 20 ms exposure time. The mean retinal sensitivity within the central 10 degrees measured with a fundus-related microperimeter, MP1, ETDRS-best corrected visual acuity (BCVA), optical coherence tomography-determined central macular thickness (CMT), and fluorescein angiography (FA) were performed before, 1, 3 and 6 months after a single treatment.

Results: Central macular thickness decreased by an average of 277 μm. At 6 months main change in visual acuity was 5 letters better. Mean macular sensitivity improved (P<0.005) at 3 and 6 months. Laser lesions were not clinically observed, but detected on the early phase of the FA examination.

Conclusions: An extensive destruction of retinal tissue with laser burns may not be necessary to achieve an effective laser therapy. In the effort to minimize the side effects while maintaining the efficacy, short pulsed and low energy laser delivery targeting a barely visible lesion endpoint may characterize a more selective alternative to the present standard of care.

Keywords: 499 diabetic retinopathy • 505 edema • 578 laser  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×